Photo by Simon Daoudi on Unsplash
Apple Resumes Smartwatch Sales After Patent Dispute
December 27, 2023
Apple has won an appeal to resume selling its smartwatches after the U.S. Court of Appeals for the Federal Circuit paused an import ban. The ban was issued by the U.S. International Trade Commission (ITC), which ruled that Apple violated patents of Masimo, a medical technology company.
The patent dispute centers on the blood oxygen monitoring technology, with Masimo accusing Apple of stealing its pulse oximetry tech. Apple countersued, suggesting Masimo’s lawsuit was a strategic move for its own smartwatch launch. While the case could cost either company millions, analysts suggest the bad publicity could be more damaging for Apple.
In a ruling on Wednesday, the appeals court stated it would pause the ban while it “considers Apple’s motion for a longer-term pause during the appeals process.” The court’s reprieve allows Apple to resume sales of its Apple Watch Series 9 and Ultra 2 models, which include the disputed technology.
“We are thrilled to return the full Apple Watch lineup to customers in time for the new year,” a representative from Apple said in a statement.
However, this pause is temporary, as the ITC has until Jan. 10 to respond to Apple’s request. The issue has raised questions about corporate ethics and technological innovation. Despite the potential financial implications of developing its own blood monitoring software, experts argue that the larger concern for Apple is the accusation of technology theft from competitors, which could impact its public image and future health wearable products.
The U.S. Customs and Border Protection is deliberating on whether the redesigned versions of Apple’s watches infringe upon Masimo’s patents and if they can be imported. The decision is due on Jan 12. In the meantime, Apple’s less expensive model, the Apple Watch SE, which lacks a pulse oximeter, is not affected by the ban, and sales continue.
Recent News
Walgreens Settlement: What You Need to Know
Walgreens recently settled a class action lawsuit, potentially putting cash in the pockets of Americans who faced job denials due to background checks. The settlement, a result of alleged Fair Credit Reporting Act violations, offers up to $918.28 to affected individuals. While Walgreens didn’t admit fault, it agreed to pay an undisclosed sum.
California Electric Bill Overhaul: What’s Ahead
California’s electricity payment system is getting a makeover. Recently, state regulators greenlit a shift to flat-rate billing, aiming to curb surging energy costs. Under this new scheme, most customers of investor-owned utility companies will face a fixed monthly charge of $24.15, trimming the per-kilowatt-hour usage fee by five to seven cents.
AI Has Mastered the Art of Deception
AI, celebrated for its productivity-boosting capabilities, harbors a deceptive side as revealed by recent research. This unsettling finding underscores the need for heightened awareness and regulatory measures to address the risks posed by AI’s ability to induce false beliefs.
Chinese EVs Navigate Global Markets Amid Rising Trade Tensions
China’s electric vehicle (EV) sector is making strategic moves into offshore markets for increased funding, exemplified by the recent success of Zeekr, a premium EV brand under Geely, which saw its shares surge 34% in the largest US IPO by a Chinese company since 2021.